Demyelination initiated by oligodendrocyte apoptosis through enhancing endoplasmic reticulum-mitochondria interactions and Id2 expression after compressed spinal cord injury in rats

CNS Neuroscience and Therapeutics

Volumn 20, Issue 1, 2014, Pages 20-31

  Huang, Si Qin ^a   Tang, Cheng Lin ^a   Sun, Shan Quan ^a   Yang, Cheng ^a   Xu, Jin ^a   Wang, Ke Jian ^a   Lu, Wei Tian ^a   Huang, Juan ^a   Zhuo, Fei ^a   Qiu, Guo Ping ^a   Wu, Xiu Yu ^b   Qi, Wei ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b HUAIHUA MEDICAL COLLEGE   (China)

Author keywords

Compressed spinal cord injury; Demyelination; Oligodendrocyte apoptosis

Indexed keywords

CASPASE 12; CYTOCHROME C; INHIBITOR OF DIFFERENTIATION 2; MYELIN BASIC PROTEIN; OSMIUM TETRAOXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL INTERACTION; CONTROLLED STUDY; DEMYELINATION; DOWN REGULATION; ENDOPLASMIC RETICULUM; IMMUNOFLUORESCENCE; INCONTINENCE; MITOCHONDRION; MYELIN SHEATH; MYELINATED NERVE; MYELINATION; NICK END LABELING; NONHUMAN; OLIGODENDROGLIA; PARALYSIS; RAT; RATING SCALE; SPASTICITY; SPINAL CORD COMPRESSION; SPINAL CORD INJURY; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING; WHITE MATTER;

COMPRESSED SPINAL CORD INJURY; DEMYELINATION; OLIGODENDROCYTE APOPTOSIS;

ANIMALS; APOPTOSIS; AXONS; BLOTTING, WESTERN; CASPASE 12; CYTOCHROMES C; DEMYELINATING DISEASES; ENDOPLASMIC RETICULUM; FLUORESCENT ANTIBODY TECHNIQUE; IN SITU NICK-END LABELING; INHIBITOR OF DIFFERENTIATION PROTEIN 2; ISCHEMIA; LUMBAR VERTEBRAE; MICROSCOPY, ELECTRON, TRANSMISSION; MITOCHONDRIA; MYELIN BASIC PROTEIN; OLIGODENDROGLIA; ORGANELLES; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD COMPRESSION;

EID: 84890563068     PISSN: 17555930     EISSN: 17555949     Source Type: Journal    
DOI: 10.1111/cns.12155     Document Type: Article

References (86)

1. Lebl DR, Hughes A, Cammisa FP Jr, O'Leary PF. Cervical spondylotic myelopathy: Pathophysiology, clinical presentation, and treatment. HSS J 2011;7:170-178.
2. Tator CH, Fehlings MG. Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J Neurosurg 1991;75:15-26.
3. Breig A, Turnbull I, Hassler O. Effects of mechanical stresses on the spinal cord in cervical spondylosis. A study on fresh cadaver material. J Neurosurg 1966;25:45.
4. Casha S, Yu W, Fehlings M. Oligodendroglial apoptosis occurs along degenerating axons and is associated with FAS and p75 expression following spinal cord injury in the rat. Neuroscience 2001;103:203.
5. Hukuda S, Wilson CB. Experimental cervical myelopathy: Effects of compression and ischemia on the canine cervical cord. J Neurosurg 1972;37:631-652.
6. McGavern DB, Murray PD, Rodriguez M. Quantitation of spinal cord demyelination, remyelination, atrophy, and axonal loss in a model of progressive neurologic injury. J Neurosci Res 1999;58:492-504.
7. Jiang S, Khan MI, Lu Y, et al. Guanosine promotes myelination and functional recovery in chronic spinal injury. NeuroReport 2003;14:2463-2467.
8. Lipton HL, Dal Canto MC. Chronic neurologic disease in Theiler's virus infection of SJL/J mice. J Neurol Sci 1976;30:201-207.
9. McGavern DB, Zoecklein L, Drescher KM, Rodriguez M. Quantitative assessment of neurologic deficits in a chronic progressive murine model of CNS demyelination. Exp Neurol 1999;158:171-181.
10. Holmes G. On the relation between loss of function and structural change in focal lesions of the central nervous system, with special reference to secondary degeneration. Brain 1907;29:514-523.
11. Blakemore W, Eames R, Smith K, McDonald W. Remyelination in the spinal cord of the cat following intraspinal injections of lysolecithin. J Neurol Sci 1977;33:31-43.
12. Jeffery N, Blakemore W. Remyelination of mouse spinal cord axons demyelinated by local injection of lysolecithin. J Neurocytol 1995;24:775-781.
13. Bai L, Lennon DP, Caplan AI, et al. Hepatocyte growth factor mediates mesenchymal stem cell-induced recovery in multiple sclerosis models. Nat Neurosci 2012;15:862-870.
14. Rodriguez M, Oleszak E, Leibowitz J. Theiler's murine encephalomyelitis: A model of demyelination and persistence of virus. Crit Rev Immunol 1987;7:325.
15. Kim BS, Jin Y-H, Meng L, et al. IL-1 signal affects both protection and pathogenesis of virus-induced chronic CNS demyelinating disease. J Neuroinflammation 2012;9:1-13.
16. Akassoglou K, Bauer J, Kassiotis G, et al. Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice: Models for multiple sclerosis with primary oligodendrogliopathy. Am J Pathol 1998;153:801-813.
17. Gong Y, Wang Z, Liang Z, et al. Soluble MOG35-55/I-Ab dimers ameliorate experimental autoimmune encephalomyelitis by reducing encephalitogenic T cells. PLoS ONE 2012;7:e47435.
18. Giacoppo S, Galuppo M, Iori R, et al. Protective role of (RS)-glucoraphanin bioactivated with myrosinase in an experimental model of multiple sclerosis. CNS Neurosci Ther. doi: 10.1111/cns.12106.
19. Bieber AJ, Warrington A, Asakura K, et al. Human antibodies accelerate the rate of remyelination following lysolecithin-induced demyelination in mice. Glia 2002;37:241-249.
20. Yang Y, Lewis R, Miller RH. Interactions between oligodendrocyte precursors control the onset of CNS myelination. Dev Biol 2011;350:127-138.
21. D'Aversa TG, Eugenin EA, Lopez L, Berman JW. Myelin basic protein induces inflammatory mediators from primary human endothelial cells and blood-brain-barrier disruption:Implications for the pathogenesis of multiple sclerosis. Neuropathol Appl Neurobiol 2013;39:270-283.
22. Boggs JM, Rangaraj G, Heng YM, Liu Y, Harauz G. Myelin basic protein binds microtubules to a membrane surface and to actin filaments in vitro: Effect of phosphorylation and deimination. Biochim Biophys Acta 2011;1808:761.
23. Barbarese E, Pfeiffer S. Developmental regulation of myelin basic protein in dispersed cultures. Proc Natl Acad Sci USA 1981;78:1953-1957.
24. Bologa L, Bisconte JC, Joubert R, Margules S, Herschkowitz N. Proliferative activity and characteristics of immunocytochemically identified oligodendrocytes in embryonic mouse brain cell cultures. Exp Brain Res 1983;50:84-90.
25. Omlin FX, Webster HD, Palkovits CG, Cohen SR. Immunocytochemical localization of basic protein in major dense line regions of central and peripheral myelin. J Cell Biol 1982;95:242-248.
26. Gavrilescu LC, Denkers EY. Apoptosis and the balance of homeostatic and pathologic responses to protozoan infection. Infect Immun 2003;71:6109-6115.
27. James ER, Green DR. Manipulation of apoptosis in the host-parasite interaction. Trends Parasitol 2004;20:280-287.
28. Moss JE, Aliprantis AO, Zychlinsky A. The regulation of apoptosis by microbial pathogens. Int Rev Cytol 1999;187:203-259.
29. Pizzo P, Pozzan T. Mitochondria-endoplasmic reticulum choreography: Structure and signaling dynamics. Trends Cell Biol 2007;17:511.
30. Florio M, Hernandez MC, Yang H, Shu HK, Cleveland JL, Israel MA. Id2 promotes apoptosis by a novel mechanism independent of dimerization to basic helix-loop-helix factors. Mol Cell Biol 1998;18:5435-5444.
31. Jessen KR, Mirsky R. Negative regulation of myelination: Relevance for development, injury, and demyelinating disease. Glia 2008;56:1552-1565.
32. Chen XS, Zhou DS, Yao ZX. The inhibitor of DNA binding 2 is mainly expressed in oligodendrocyte lineage cells in adult rat brain. Neurosci Lett 2007;428:93-98.
33. Kondo T, Raff M. Basic helix-loop-helix proteins and the timing of oligodendrocyte differentiation. Development 2000;127:2989-2998.
34. Dutta R, Trapp BD. Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis. Prog Neurobiol 2011;93:1-12.
35. Basso DM, Beattie MS, Bresnahan JC. Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. Exp Neurol 1996;139:244-256.
36. Pavelko KD, van Engelen BG, Rodriguez M. Acceleration in the rate of CNS remyelination in lysolecithin-induced demyelination. J Neurosci 1998;18:2498-2505.
37. Leviton A, Gilles F. Ventriculomegaly, delayed myelination, white matter hypoplasia, and "periventricular" leukomalacia: How are they related? Pediatr Neurol 1996;15:127-136.
38. Blumenthal I. Periventricular leucomalacia: A review. Eur J Pediatr 2004;163:435-442.
39. Volpe JJ, Kinney HC, Jensen FE, Rosenberg PA. The developing oligodendrocyte: Key cellular target in brain injury in the premature infant. Int J Dev Neurosci 2011;29:423-440.
40. Arduíno DM, Esteves AR, Cardoso SM, Oliveira CR. Endoplasmic reticulum and mitochondria interplay mediates apoptotic cell death: Relevance to Parkinson's disease. Neurochem Int 2009;55:341-348.
41. Orrenius S. Mitochondrial regulation of apoptotic cell death. Toxicol Lett 2004;149:19-23.
42. Morishima N, Nakanishi K, Takenouchi H, Shibata T, Yasuhiko Y. An endoplasmic reticulum stress-specific caspase cascade in apoptosis cytochrome c-independent activation of caspase-9 by caspase-12. J Biol Chem 2002;277:34287-34294.
43. Harkey HL, Al-Mefty O, Marawi I, Peeler DF, Haines DE, Alexander LF. Experimental chronic compressive cervical myelopathy: Effects of decompression. J Neurosurg 1995;83:336-341.
44. Siegal T, Siegal T, Shapira Y, Sandbank U, Catane R. Indomethacin and dexamethasone treatment in experimental neoplastic spinal cord compression: Part 1: Effect on water content and specific gravity. Neurosurgery 1988;22:328-333.
45. Yu WR, Fehlings MG. Fas/FasL-mediated apoptosis and inflammation are key features of acute human spinal cord injury: Implications for translational, clinical application. Acta Neuropathol 2011;122:747-761.
46. Maegele M, Riess P, Sauerland S, et al. Characterization of a new rat model of experimental combined neurotrauma. Shock 2005;23:476-481.
47. Profyris C, Cheema SS, Zang D, Azari MF, Boyle K, Petratos S. Degenerative and regenerative mechanisms governing spinal cord injury. Neurobiol Dis 2004;15:415-436.
48. Linden J. Adenosine in tissue protection and tissue regeneration. Mol Pharmacol 2005;67:1385-1387.
49. Hagg T, Oudega M. Degenerative and spontaneous regenerative processes after spinal cord injury. J Neurotrauma 2006;23:263-280.
50. Mizuno J, Nakagawa H, Inoue T, Hashizume Y. Clinicopathological study of "snake-eye appearance" in compressive myelopathy of the cervical spinal cord. J Neurosurg Spine 2003;99:162-168.
51. Yamaura I, Yone K, Nakahara S, et al. Mechanism of destructive pathologic changes in the spinal cord under chronic mechanical compression. Spine 2002;27:21-26.
52. Kim P, Haisa T, Kawamoto T, Kirino T, Wakai S. Delayed myelopathy induced by chronic compression in the rat spinal cord. Ann Neurol 2004;55:503-511.
53. Lingor P, Koch JC, Tönges L, Bähr M. Axonal degeneration as a therapeutic target in the CNS. Cell Tissue Res 2012;349:289-311.
54. twlHe F, Fan Q, Cushway T, et al. Long-term result of guided nerve regeneration with an inert microporous polytetrafluoroethylene conduit. Chin J Traumatol 2003;6:145.
55. Kurihara K, Cohen M, Schultz RC. Nerve staining with leucomethylene blue: An experimental study. Plast Reconstr Surg 1984;73:960-964.
56. Gu X, Yan Z, Yan W, Chen C. Rapid immunostaining of live nerve for identification of sensory and motor fasciculi. Chin Med J (Engl) 1992;105:949.
57. Starega U. A silver impregnation technique for normal axons in the human central nervous system for celloidin and Epon sections, with substitutes for soft tap water. Stain Technol 1985;60:103-110.
58. Wei LP, He FC, Chen XW, Lu SB, Lanzetta M, De Iongh R. Osmic acid staining of myelin sheath in normal and regenerated peripheral nerves. Chin J Traumatol 2007;10:86-89.
59. Dogan R-NE, Elhofy A, Karpus WJ. Production of CCL2 by central nervous system cells regulates development of murine experimental autoimmune encephalomyelitis through the recruitment of TNF-and iNOS-expressing macrophages and myeloid dendritic cells. J Immunol 2008;180:7376-7384.
60. Cross AH, Dolich S, Raine CS. Antigen processing of myelin basic protein is required prior to recognition by T cells inducing EAE. Cell Immunol 1990;129:22-31.
61. D'Souza CA, Moscarello MA. Differences in susceptibility of MBP charge isomers to digestion by stromelysin-1 (MMP-3) and release of an immunodominant epitope. Neurochem Res 2006;31:1045-1054.
62. Mastronardi FG, Moscarello MA. Molecules affecting myelin stability: A novel hypothesis regarding the pathogenesis of multiple sclerosis. J Neurosci Res 2005;80:301-308.
63. Ackery A, Robins S, Fehlings MG. Inhibition of Fas-mediated apoptosis through administration of soluble Fas receptor improves functional outcome and reduces posttraumatic axonal degeneration after acute spinal cord injury. J Neurotrauma 2006;23:604-616.
64. Emery E, Aldana P, Bunge MB, et al. Apoptosis after traumatic human spinal cord injury. J Neurosurg 1998;89:911-920.
65. Yoshino O, Matsuno H, Nakamura H, et al. The role of Fas-mediated apoptosis after traumatic spinal cord injury. Spine 2004;29:1394-1404.
66. Lucchinetti CF, Brück W, Rodriguez M, Lassmann H. Distinct patterns of multiple sclerosis pathology indicates heterogeneity in pathogenesis. Brain Pathol 1996;6:259-274.
67. Shuman SL, Bresnahan JC, Beattie MS. Apoptosis of microglia and oligodendrocytes after spinal cord contusion in rats. J Neurosci Res 1997;50:798-808.
68. Takagi T, Takayasu M, Mizuno M, Yoshimoto M, Yoshida J. Caspase activation in neuronal and glial apoptosis following spinal cord injury in mice. Neurol Med Chir 2003;43:20-30.
69. Rasheva VI, Domingos PM. Cellular responses to endoplasmic reticulum stress and apoptosis. Apoptosis 2009;14:996-1007.
70. Tan Y, Dourdin N, Wu C, De Veyra T, Elce JS, Greer PA. Ubiquitous calpains promote caspase-12 and JNK activation during endoplasmic reticulum stress-induced apoptosis. J Biol Chem 2006;281:16016-16024.
71. Nakagawa T, Zhu H, Morishima N, et al. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β. Nature 2000;403:98-103.
72. Zhang HY, Zhang X, Wang ZG, et al. Exogenous basic fibroblast growth factor inhibits ER stress-induced apoptosis and improves recovery from spinal cord injury. CNS Neurosci Ther 2013;19:20-29.
73. Nicholls DG. Mitochondrial function and dysfunction in the cell: Its relevance to aging and aging-related disease. Int J Biochem Cell Biol 2002;34:1372-1381.
74. Hajnóczky G, Csordás G, Das S, et al. Mitochondrial calcium signalling and cell death: Approaches for assessing the role of mitochondrial Ca2+ uptake in apoptosis. Cell Calcium 2006;40:553.
75. Chami M, Oulès B, Szabadkai G, Tacine R, Rizzuto R, Paterlini-Bréchot P. Role of SERCA1 truncated isoform in the proapoptotic calcium transfer from ER to mitochondria during ER stress. Mol Cell 2008;32:641-651.
76. Zhao CQ, Zhang YH, Jiang SD, Jiang LS, Dai LY. Both endoplasmic reticulum and mitochondria are involved in disc cell apoptosis and intervertebral disc degeneration in rats. Age (Dordr) 2010;32:161-177.
77. Bhattarai G, Lee YH, Lee NH, et al. Fomitoside-K from fomitopsis nigra induces apoptosis of human oral squamous cell carcinomas (YD-10B) via mitochondrial signaling pathway. Biol Pharm Bull 2012;35:1711-1719.
78. Cohen MV, Baines CP, Downey JM. Ischemic preconditioning: From adenosine receptor to KATP channel. Annu Rev Physiol 2000;62:79-109.
79. Garrido C, Bruey JM, Fromentin A, Hammann A, Arrigo AP, Solary E. HSP27 inhibits cytochrome c-dependent activation of procaspase-9. FASEB J 1999;13:2061-2070.
80. McLaughlin B, Hartnett KA, Erhardt JA, et al. Caspase 3 activation is essential for neuroprotection in preconditioning. Proc Natl Acad Sci USA 2003;100:715-720.
81. Benezra R, Davis RL, Lockshon D, Turner DL, Weintraub H. The protein Id: A negative regulator of helix-loop-helix DNA binding proteins. Cell 1990;61:49-59.
82. Bhattacharya A, Baker NE. A network of broadly expressed HLH genes regulates tissue-specific cell fates. Cell 2011;147:881-892.
83. Niola F, Zhao X, Singh D, et al. Id proteins synchronize stemness and anchorage to the niche of neural stem cells. Nat Cell Biol 2012;14:477-487.
84. Bilbault P, Lavaux T, Launoy A, et al. Influence of drotrecogin alpha (activated) infusion on the variation of Bax/Bcl-2 and Bax/Bcl-xl ratios in circulating mononuclear cells: A cohort study in septic shock patients. Crit Care Med 2007;35:69-75.
85. Kumari A, Kakkar P. Lupeol prevents acetaminophen-induced in vivo hepatotoxicity by altering the Bax/Bcl-2 and oxidative stress-mediated mitochondrial signaling cascade. Life Sci 2012;90:561-570.
86. Almad A, Sahinkaya FR, McTigue DM. Oligodendrocyte fate after spinal cord injury. Neurotherapeutics 2011;8:262-273.